首页> 外国专利> New oligosaccharides obtained by forming anhydro-sugar residue in heparin depolymerization product, are nitrogen monoxide formation inhibitors useful e.g. for treating ischemia, osteoarthritis or neuropathic pain

New oligosaccharides obtained by forming anhydro-sugar residue in heparin depolymerization product, are nitrogen monoxide formation inhibitors useful e.g. for treating ischemia, osteoarthritis or neuropathic pain

机译:通过在肝素解聚产物中形成脱水糖残基而获得的新的低聚糖是一氧化氮的形成抑制剂,例如可用于抗氧化剂。用于治疗局部缺血,骨关节炎或神经性疼痛

摘要

Oligosaccharides (I), containing a terminal 1,6-anhydro-2-deoxy-2-amino- beta -D-mannopyranose unit, are new. Oligosaccharides of formula (I) and their mixtures and diastereomers, containing a terminal 1,6-anhydro-2-deoxy-2-amino- beta -D-mannopyranose unit, are new. n = 0-25; R1, R3-R5 = H or SO3M; R2, R6 = H, SO3M or COMe, and M = Na, Ca, Mg or K. An Independent claim is included for the preparation of (I).
机译:含有末端1,6-脱水-2-脱氧-2-氨基-β-D-甘露吡喃糖单元的寡糖(I)是新的。含有末端1,6-脱水-2-脱氧-2-氨基-2-氨基-β-D-甘露吡喃糖单元的式(I)的寡糖及其混合物和非对映异构体是新的。 n = 0-25; R1,R3-R5 = H或SO3M; R 2,R 6 = H,SO 3 M或COMe,并且M = Na,Ca,Mg或K。包括独立的权利要求用于制备(I)。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号